# Role of Heme Oxygenase in the Pathogenesis of Hepatocellular Injury in Chronic Hepatitis C Virus (HCV) Infection

> **NCT00842205** · NA · UNKNOWN · sponsor: **Charles University, Czech Republic** · enrollment: 150 (estimated)

## Conditions studied

- Chronic HCV Infection
- Nonalcoholic Steatohepatitis

## Interventions

- **DRUG:** pegylated interferon
- **DRUG:** Ribavarin

## Key facts

- **NCT ID:** NCT00842205
- **Lead sponsor:** Charles University, Czech Republic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-01
- **Primary completion:** 2009-06
- **Final completion:** 2009-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2009-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00842205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00842205, "Role of Heme Oxygenase in the Pathogenesis of Hepatocellular Injury in Chronic Hepatitis C Virus (HCV) Infection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00842205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*